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Abstract Recently, it has become apparent that a
metacognitive perspective may contribute to the
understanding and treatment of psychopathology. In
this study, the effect of a cognitive-behavioural
psychoeducational group treatment for hypochondri-
asis on metacognitive aspects was examined.
Furthermore, it was studied whether earlier found
beneficial effects of the course on hypochondriacal
complaints, depressive complaints and trait anxiety
could be replicated. A total of 35 participants were
randomized into either an immediate treatment group
(n = 20), or a waiting list control group (n = 15). The
participants in the waiting list control group were
enrolled in the treatment after a period of 6 weeks.
Results showed that the course had an effect on all
subscales of the Metacognition-Cognitions about
Health Anxiety questionnaire. Furthermore, in line
with previous findings, the course proved to be
effective in decreasing hypochondriacal complaints,
depressive complaints and trait anxiety. It may be
concluded that cognitive-behavioural psychoeduca-
tional treatment, in which a metacognitive level is
implicitly addressed, shows beneficial effect on meta-
cognitive aspects and hypochondriacal complaints.




The central mechanism in people suffering from
hypochondriasis is a relatively enduring tendency to
misinterpret bodily symptoms, bodily variations, and
other health-related information, as evidence of
serious physical illness (Asmundson et al. 2001).
According to the cognitive-behavioural hypothesis of
health anxiety and hypochondriasis (Warwick and
Salkovskis 1990), bodily signs and symptoms are
perceived as more dangerous than they really are, and
the chance of contracting a particular disease is
believed to be more probable than it really is
(Salkovskis 1989; Salkovskis and Warwick 1986;
Warwick and Salkovskis 1989). This cognitive
hypothesis accounts for the development of hypo-
chondriasis, in that knowledge and past experiences
of disease lead to the formation of specific
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assumptions about symptoms, disease and health
behaviours. These assumptions will often lead to a
confirmatory bias in the patient’s thinking once a
critical incident has resulted in the misinterpretation
of bodily symptoms and signs as being indications of
a serious disease. Mechanisms that are subsequently
involved in the maintenance of hypochondriacal
complaints are anxiety -resulting in physical arou-
sal-, selective attention -such as the perception of
normal bodily changes, and previously unnoticed
bodily features-, and behaviour, designed to avoid,
check for or exclude physical disease.
Metacognitive processes might explain how mis-
interpretation can play a continuing role in the
maintenance of hypochondriasis. Metacognition is
any knowledge or cognitive process that is involved
in the appraisal, monitoring, or control of cognition
(Flavell 1979). A distinction has been made between
three components of metacognition: metacognitive
knowledge, metacognitive experiences, and metacog-
nitive control strategies (Wells 2000). These three
components can help explain why metacognition has
been hypothesized to play a part in emotional
disorders. Metacognitive knowledge refers to the
information that people have about their own cogni-
tions, such as beliefs about the meaning of particular
types of thoughts (such as worrying), and beliefs
concerning the efficiency of memory and cognitive
control (Wells 2000). Metacognitive knowledge can
be explicit and accessible to patients. Examples of
explicit metacognitive knowledge are: ‘I cannot
control my worrying’, or ‘If I think about cancer so
much, I will get it’. However, metacognitive knowl-
edge can also operate in an implicit way, and forms
the rules or plans that guide processing, such as
attention allocation (Wells 2000).
Secondly, metacognitive experiences include
appraisals of the meaning of specific mental events,
metacognitive feelings and judgements of the status
of cognition (Wells 2000). Thirdly, metacognitive
control strategies are the responses individuals make
in controlling the activities of their cognitive system
(Wells 2000). In clinical disorders, control strategies
often consist of attempts to control the stream of
consciousness.
It was hypothesized that metacognitive processes
operate on two different levels, which are inter-
related: the meta-level and the object-level (Nelson
and Narens 1990). Information flows to and from
both levels, and is called monitoring when the object-
level informs the meta-level of its state, and control
when the meta-level informs the object-level what to
do next. It is thought that the meta-level is controlled
and modified by feedback about the effectiveness of
particular cognitive and behavioural strategies in
relation to activated goals (Wells and Matthews
1994), thereby providing information about future
preferred actions and cognitions.
The Metacognition Questionnaire (MCQ; Cart-
wright-Hatton and Wells 1997) was devised to assess
individual differences in the aforementioned meta-
cognitive aspects. The MCQ consists of several
subscales: (a) positive beliefs about worry, referring
to the extent to which a person feels that worrying is
helpful, (b) negative beliefs about worry, concerning
uncontrollability and danger, (c) cognitive confidence,
such as confidence in attention and memory, (d)
negative beliefs concerning the consequences of not
controlling one’s own thought, and (e) cognitive self-
consciousness, referring to the tendency to monitor
one’s own thoughts and focus attention inwards.
In recent studies investigating metacognitive
aspects, several disorders were found to be influenced
by metacognition. A study of depression (Papageor-
giou and Wells 2003) showed a relationship between
metacognition, rumination and depression. Further-
more, the study showed that positive beliefs about
rumination could be associated with the activation of
rumination. Furthermore, rumination appeared to lead
to symptoms of depression, directly or indirectly, via
negative metacognitive beliefs about the interper-
sonal and social consequences of ruminating.
Metacognition was also found to play a role in
anxiety disorders. Obsessive compulsive disorder
(Wells and Papageorgiou 1998) was found to be
influenced by metacognition: both positive beliefs
and negative beliefs about worry concerning themes
of uncontrollability and danger were positively
associated with proneness to pathological worry in
obsessive compulsive disorder. All MCQ subscales
were significantly and positively correlated with
obsessional checking and obsessional thoughts. A
relationship between generalised anxiety disorder and
metacognitive aspects has also been shown (Wells
and Carter 2001). Generalized anxiety disordered
patients had higher meta-worry and negative meta-
cognitive belief scores than social phobic patients,
panic disordered patients, depressed patients and
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nonpatients. A most recent study showed a relation-
ship between post-traumatic stress disorder and
metacognitive aspects (Roussis and Wells 2006). In
this study it was hypothesized that worry and specific
positive and negative metacognitive beliefs would be
positively associated with stress symptoms. Indeed,
results showed that thought control strategies of
worry, and positive and negative metacognitions
were positively associated with stress symptoms.
As yet, it has only been studied once whether
metacognitive aspects played a role in, or were related
to, hypochondriacal complaints (Bouman and Meijer
1999). The researchers adapted the MCQ for use with
hypochondriacal patients, resulting in the Metacogni-
tion-Cognitions about Health Anxiety (MCHA). This
scale measures beliefs and attitudes in connection with
anxious thoughts about health, illness, and disease.
Specific metacognitive areas, captured in the instru-
ment’s subscales, are uncontrollability and interference,
self-consciousness, responsibility, and positive and
negative consequences of thinking about illness.
Results of the study showed that metacognition played
a part in hypochondriasis: hypochondriacal patients
specifically had many worrisome thoughts about their
health. On a metacognitive level they were concerned
about the lack of control, and the excess of interference
they experienced in relation to their illness-worries.
They proved highly aware of their own thoughts and
worries, and content-specific meta-worry appeared to
be the best predictor for hypochondriasis. Hypochon-
driacal patients did not score higher on positive beliefs
and responsibility than healthy controls and psychology
students. However, because only 14 patients suffering
from hypochondriasis participated, and this study was
the first to examine the relationship between metacog-
nition and hypochondriasis, it is too early to conclude as
yet that these two metacognitive aspects do not play a
role in hypochondriasis. Furthermore, clinical experi-
ence suggests that the metacognitive aspects that are
measured using the MCHA may well play a role in the
maintenance of hypochondriasis.
For one, uncontrollability is manifest in that
hypochondriacal patients tend to regard their cogni-
tions and worries about illness as almost impossible to
control. Furthermore, they seem to believe they have
the responsibility not to get a serious disease, or to
prevent an already contracted disease from getting
worse, for example by visiting physicians and seeking
reassurance from their partners or others. Also,
hypochondriacal patients are known to display self-
consciousness: when worrying about a disease they
report to find it very difficult to focus their attention on
anything else than their bodily sensations.
Hypochondriacal patients state that they often try
to stop thinking catastrophically, but that they are
somehow not able to do so, perhaps because the ways
in which they attempt to control their cognitions are
unhelpful. Firstly, as a result of the negative conse-
quences of cognition perhaps, they try to force
themselves to stop thinking about illness, and not be
confronted with illness. Therefore, people suffering
from hypochondriasis tend to avoid disease related
situations and information. Secondly, hypochondria-
cal patients allow themselves to ruminate about their
health, possibly as a result from the positive conse-
quences they believe thinking about disease has.
An important question is how those metacognitive
aspects that maintain emotional disorders can be
addressed in clinical practice. One way to do so is by
developing metacognitive treatments, which explic-
itly focus on metacognition. This has been done by
Wells (1999, 2000), at first for GAD, and later for
post-traumatic stress disorder (Wells and Sembi
2004). In metacognitive treatment, the emphasis lies
on eliciting and modifying negative and positive
beliefs about worrying. Furthermore, alternative non-
worry-based strategies for appraising and dealing
with threat are developed as part of the treatment.
Participants are made specifically aware of their
metacognitions and how to change them.
However, specific metacognitive interventions
might not be necessary for every disorder in which
metacognitive aspects play a role, because metacogni-
tions may also implicitly be influenced by certain
treatments. Cognitive-behavioural psychoeducational
treatment is one of the treatment forms in which this
may happen, because participants are taught that their
cognitions and behaviours are not as uncontrollable and
dangerous as they seem. These new insights might lead
to a change in metacognition, in terms of participants
gaining control over their thoughts and actions without
having discussed metacognitive aspects. Furthermore,
during cognitive-behavioural psychoeducational treat-
ment participants are taught how to monitor, appraise
and control their thoughts and behaviour in a different
and more adaptive way, possibly leading to different
patterns of behaviour and a different perception on
worrying about illness as well.
Cogn Ther Res (2008) 32:689–701 691
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In recent years, short-term psychoeducational
courses based on the cognitive-behavioural approach
have shown to be effective in reducing hypochondri-
acal complaints (Avia et al. 1996; Barsky et al. 1988;
Bouman 2002; Buwalda et al. 2007; Stern and
Fernandez 1991). In the present study, we investigate
whether the Dutch course, called ‘Coping with health
anxiety’ is effective in changing metacognitions.
The research has two main aims: the first is to
examine whether the ‘Coping with health anxiety’
course can produce a change in several aspects of
metacognition, operationalized as the MCHA sub-
scales, and hypochondriacal complaints. It is hypo-
thesized that all measured aspects of metacognition
(uncontrollability and interference, self-consciousness,
responsibility, and positive and negative consequences
of thinking about illness) decrease after the course,
having been implicitly addressed through the psycho-
educational treatment. The second goal of the study is
to replicate earlier found beneficial effects of the course
on hypochondriacal complaints, depressive com-
plaints, which hypochondriacal patients often also
suffer from, and trait anxiety. The course is expected to
positively affect hypochondriacal complaints, depres-
sive symptomatology and trait anxiety.
Method
Recruitment, Screening and Randomization
Participants were recruited by notifying the local
press, local radio networks, General Practitioners
(GP’s), and low threshold general health care facilities
a few times over a period of 4 years (2002–2005). The
course was open to self-referral, and was introduced
as a way of learning how to handle health anxiety, and
of gaining insight into hypochondriacal complaints.
Potential participants were screened for psycho-
pathology using a structured 30 min telephone
interview. This interview is a condensed version of
the Anxiety Disorders Interview Schedule (Bouman
et al. 1997; DiNardo et al. 1994) in which only the
main criteria for DSM-IV (APA 1994) somatoform,
anxiety and mood disorders were screened, with a
specific emphasis on hypochondriacal complaints. An
example of how only the main criteria of anxiety
disorders were screened is: when inquiring into
generalized anxiety disorder, the interviewer merely
asked whether or not there were multiple things the
participant worried about, whether this worrying had
increased over the last 6 months, and whether it was
difficult to stop worrying about these things. Partic-
ipants were also asked about previous psychological
treatment. The interview led to an evaluation of the
presence or absence of symptoms of any of the
disorders mentioned above.
Inclusion criteria were: (1) the presence of a DSM-
IV diagnosis of hypochondriasis, (2) being over
18 years old, (3) having active command of the
Dutch language, and (4) being willing to participate
actively in the course. Exclusion criteria were: (1) the
presence of other DSM-IV Axis I disorders more
prominent than hypochondriasis, (2) the presence of a
serious somatic disease as the focus of the health
anxiety, and (3) a previous or concurrent cognitive-
behavioural treatment for hypochondriasis. The par-
ticipants using psychotropic medication when
entering the study (n = 13), were asked to keep their
dosage constant for the sake of the study.
Informed consent was obtained at the end of the
telephone interview, by first giving potential partic-
ipants information about the nature of the study, and
then informing them they were free to stop their
participation in the research at any given time,
without this interfering with their participation in
the course. They then were asked if they agreed to
these terms. None of the candidate participants
refused to participate in the study.
Participants were randomly assigned to either the
immediate treatment condition, or the waiting list
condition, by order of application: once 6–8 partic-
ipants had applied, and had been included, either an
immediate treatment- or a waiting list group started.
The waiting list period lasted 6 weeks, after which
period participants were enrolled in treatment. The
randomisation was undertaken irrespective of patient
characteristics, and was performed by the first author.
The courses were taught at a Home Care organiza-
tion, as well as at the Department of Clinical
Psychology of the University of Groningen, where
the research was conducted.
Participants
Of the 57 people interested in the course, 35
participants were randomized to the course, implying
692 Cogn Ther Res (2008) 32:689–701
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that 22 aspiring participants declined to participate.
Two of them preferred individual treatment, 4 of
them were already treated elsewhere, one was unable
to attend the course, three of them decided that their
complaints were not severe enough to require treat-
ment, three of them were suffering primarily from
other complaints, another three could not be reached
after the initial contact, five candidates had lost their
interest after the telephone interview, and one
candidate’s proficiency in Dutch was insufficient.
The 35 participants were randomised into six
groups: three immediate treatment groups (total n =
20), and three waiting list groups (total n = 15), of
5–8 participants. Four (11.4%) participants dropped
out of the course, after the first or following sessions
(two in the immediate treatment group, and two in the
waiting list group), of whom one participant stopped
coming after the second session and was impossible
to contact thereafter, one could not attend because of
obligations at work, one stopped because a benign
cause of her bodily symptoms was found and she
decided she did not need the course anymore, and one
felt the course did not suit her problems. In the
immediate treatment condition, 18 participants com-
pleted the course, and of the waitlist condition, 13
participants did so. Of the 31 course completers, 26
participants returned the post assessment (14 of the
immediate treatment condition, and 12 of the waiting
list condition). A total of 26 completers returned the
1 month follow-up (14 participants of the immediate
treatment condition, and 12 of the waiting list
condition), and 22 completers returned the 6 month
follow-up (11 participants of the immediate treatment
condition, and 12 of the waiting list condition).
Of the participants, 21 (60%) were female, and the
mean age was 38.2 years (SD = 10.6). A total of 23
participants (65.7%) were cohabitating or married.
Eleven (31.4%) of the participants had a high
(academic or professional) educational level, 15
(42.9%) of the participants had a medium (higher
secondary) level of education, and 8 (22.9%) had a
low (lower secondary) educational level. Mean
duration of hypochondriacal complaints is 12.3 years
(SD = 10.3, range 6 months–41 years). Chi-square
testing and t-tests showed no significant differences
between the conditions regarding either of these
demographic variables.
Only participants who, during the telephone diag-
nostic interview, stated that their primary complaint
was hypochondriasis and that they specifically
required help with regard to these complaints, were
included in this study, and were informed that
hypochondriacal complaints would be the sole focus
of the course. However, comorbid complaints were
also evaluated shortly during the diagnostic telephone
interview. A total of 17 participants suffered to some
extent from panic attacks, and 12 from general
anxiety complaints. Six participants reported agora-
phobic complaints. Furthermore, 13 participants
reported some form of specific phobic complaint,
whereas 8 suffered from social phobic complaints.
Three participants suffered from a moderate form of
obsessive compulsive complaints. Regarding depres-
sive episodes, a total of 27 participants had suffered
from these, either at time of intake or in the past.
Most participants stated that these depressive com-
plaints were related to their hypochondriacal
complaints. We have no information regarding
comorbidity of 3 participants. A substantial number
of participants suffered from symptoms of more than
one anxiety- or depressive complaint. Between the
participants of the immediate treatment- and the
waiting list condition there were no significant
differences with regard to the occurrence of comorbid
complaints, according to chi-squared test.
Procedure
The course ‘Coping with health anxiety’ was imple-
mented as a six 2-hour session format, each of those
consisting of a mixture of mini-lectures, demonstra-
tions, video illustrations, focused group discussions
and brief exercises. The course’s theory is based on
the cognitive-behavioural model by Warwick and
Salkovskis (1990), which describes several mecha-
nisms that are subsequently involved in the
maintenance of hypochondriacal complaints. These
mechanisms are bodily symptoms, cognitions (about
these symptoms), anxiety (resulting in physical
arousal), selective attention (such as the perception
of normal bodily changes, and previously unnoticed
bodily features), and behaviour, designed to avoid,
check for, or exclude, physical disease. Every session
of the course is based on one such mechanism, and
consists of detailed explanation and practical exer-
cises. In order to increase personal relevance and
active mastery of the information provided, the
Cogn Ther Res (2008) 32:689–701 693
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facilitators try to elicit as many examples and
responses as possible from the participants them-
selves. Sessions one to five are followed by brief,
optional, homework assignments. A booster session
is held 4 weeks after session six. The course is
described in more detail elsewhere (Bouman 2002;
Bouman and Buwalda in press).
Each group was coached by two facilitators. The
group of facilitators consisted of one PhD-student,
with 3 years of experience with both individual CBT
for hypochondriasis, and the course ‘Coping with
health anxiety’ (first author), and several graduate
students of clinical psychology (all females, in their
early twenties). All facilitators had some experience
with individual cognitive-behavioural treatment for
hypochondriasis; some had previous experience with
coaching courses. A detailed session-by-session
manual was provided and used by the facilitators,
and they received a 3-h training in teaching the
course, provided by the first author. During the
training, the manual was discussed and facilitators
were taught how to handle certain situations that may
arise during the course, such as the participants not
paying attention, or one participant seeking more
attention and guidance by the facilitators than the
others. The facilitators were supervised weekly by the
first author, to discuss progress, specific content of
the sessions, and to detect and solve possible
problems. These supervision sessions also served as
a way to qualitatively assess adherence to the manual.
Having two facilitators teaching the course served as
a safeguard for treatment fidelity, as did having them
write down detailed session reports.
Measurements
Repeated measures were taken pre-treatment, post-
treatment, at 1 month after the course had ended, and
at 6 months after the ending of treatment.
Primary Outcome Measures
Hypochondriacal Complaints
The Groningen Illness Attitude Scale (GIAS; Bouman
2002; Visser 2000) is a 42-item self-report question-
naire that measures four aspects of hypochondriasis:
‘disease conviction’ (15 items; a = 0.92), ‘bodily
symptoms and complaining’ (12 items; a = 0.88),
‘health anxiety and thanatophobia’ (8 items;
a = 0.85), and ‘checking and avoidance behaviour’
(7 items; a = 0.71) (Bouman 2002). The GIAS is
based on the Illness Attitude Scales (Kellner 1986) and
the Whitely Index (Pilowsky 1967). The applicability
of each item during the seven days prior to assessment
is scored on a 5-point scale (from 1 = ‘never’, to
5 = ‘nearly always’). The questionnaire has satisfac-
tory discriminative validity, and strong convergent
validity (Visser 2000). In this study, the analyses will
be done using the total scale of the GIAS.
Metacognition
The Metacognition-Cognitions about Health Anxiety
(MCHA; Bouman and Meijer 1999) is a question-
naire containing 27 items measuring several
components of metacognition. Items are scored on a
scale from 1 (‘do not agree’) to 4 (‘agree very
much’). The 5 scales are: (a) Uncontrollability and
interference of illness thoughts (12 items, e.g. ‘I find
it hard to ignore thoughts about serious diseases’;
a = 0.93), (b) Cognitive self-consciousness (4 items,
e.g. ‘I am very aware of the way I think about
illness’; a = 0.74), (c) Responsibility (3 items, e.g. ‘I
can protect myself from getting a serious illness by
thinking about this a lot’; a = 0.70), (d) Negative
consequences (5 items, e.g. ‘I believe I can make
myself sick by worrying about illness’; a = 0.70),
and e) Positive beliefs (3 items, e.g. ‘Worrying about
diseases helps me to cope with my fear of them’;
a = 0.62). The moderate internal consistencies of all




Beck’s Depression Inventory (Beck et al. 1979;
Dutch version: Bouman et al. 1985) measures the
severity of depressive symptoms and consists of 21
groups of 4 statements describing depressive symp-
toms, from which the patient chooses the most
applicable. Cronbach’s a’s of this measure ranged
694 Cogn Ther Res (2008) 32:689–701
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from .73 to .92 within patient groups (Bouman et al.
1985).
Trait Anxiety
The trait scale of the Dutch authorized version of the
State-Trait Anxiety Inventory (Dutch version: van der
Ploeg et al. 1980) was used. This scale consists of 20
items and measures inter-individual differences in
anxiety. The trait-scale has a Cronbach’s a ranging
between .91 (for college students) and .93 (for a
patient normgroup) (Van der Ploeg et al. 1980).
Results
Analytic Plan
The effect of the course on metacognitive aspects
over time was analysed using multilevel analysis. In
contrast to standard methods for analysing repeated
measurements, multilevel analysis does not require
data on all measurements for each individual, but
uses all available observations. In addition to some
drop-out in the study described before, missing data
occur due to the setup of the study: participants in the
waiting list condition have one (earlier) extra mea-
surement in comparison to participants in the
immediate treatment condition. The structure of the
data is depicted in Figure 1, where the measurements
of participants in the waiting list and treatment
condition are aligned at t2, the start of the course.
Time t1 indicates the first measurement, only avail-
able for participants in the waiting list condition. In
Fig. 1 also a few cases of dropout are visible,
indicated with open triangles and circles for dropout
before treatment. Dropout later in the study is
apparent when individual lines are discontinued at
for instance t3, indicating that no further measure-
ments are available for follow-up after the course.
In multilevel analysis of repeated measurements,
the observations (level 1) are nested in individuals
(level 2). A first step in the analysis is to establish the
covariance structure of the repeated measurements
(comparable to the choice between the univariate or
multivariate approach in repeated measures analysis
of variance). Theoretically, a third level could have
been included in the model, representing the variable
‘group’. However, due to the small amount of groups
in this study, this was not a feasible option.
Multilevel models were estimated for the sub-
scales of the MCHA and its total scale to investigate
the effect of the course on metacognitive aspects over
time, using dummy variables for the first measure-
ment for the waiting list condition (t1) and for the
measurement immediately after the course (t3) and
the two followup measurements (t4 and t5), thus
using the measurement at the start of the course as the
reference time for both waiting list and immediate
treatment conditions. Moreover, the difference
between the immediate treatment condition and the
waiting list condition was tested and left out of the
model if not significant.
Fig. 1 The scores of all participants on metacognitive aspects
and hypochondriacal complaints
Cogn Ther Res (2008) 32:689–701 695
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To check whether participants with complete
assessments differed from participants with missing
data, the dummy variables for attrition based on the
number of returned questionnaires was inserted in the
multilevel models for every outcome measure. The
dummy variable pertained to drop outs of the course,
completers who returned one assessment, completers
who returned three assessments, completers who
returned a variable number of assessments in a
random fashion (e.g. no pre-assessment, but follow-
up one and two), and completers who returned all
assessments. None of the completers returned two
assessments, therefore this option is not included as a
dummy variable. Only significant missing data
dummy variables were retained in the model. The
effect of biographical variables age, gender, and level
of education was also investigated in the multilevel
analysis. Non-significant variables were left out of
the multilevel model.
The same model setup and selection was used for
estimating the course effect on the GIAS measuring
hypochondriacal complaints, the BDI measuring
depressive complaints, and for the STAI measuring
trait anxiety.
The statistical significance of single fixed effects is
tested by approximate t-tests (Snijders and Bosker
2000), of which two-sided p-values are reported. In
addition, the effect sizes of the post versus pre
assessment difference, defined as the estimated
difference between pre and post assessment, standar-
dised using the estimated total standard deviation
(Raudenbush 1997).
Multilevel Analysis Model Selection Results for
All Dependent Variables
A multilevel model with just a level 1 (within-
subject) variance and a level 2 (between-subjects)
variance was adequate for all dependent variables.
This model corresponds to a compound symmetry
model, assuming constant measurement variance and
correlation between measurements over time. Both
between- and within-subject variances for all vari-
ables are relatively large, which is also apparent from
Fig. 1 with a large spread of lines (between subjects)
and rather jagged individual lines (within-subjects).
The between individual variance of all subscales was
smaller than the measurement variance, meaning that
scores of individuals differed less between subjects
than within subjects. Only for subscales negative
consequences and positive beliefs both types of
variance did not differ substantially, indicating a
resemblance in the pattern of fluctuation over time
within individuals and between individuals.
When inserted into the models of all outcome
measures (MCHA, GIAS, STAI, and BDI), only the
drop out indicator showed an effect on the GIAS and
was therefore included in the model of this measure.
None of the biographical variables (age, gender, and
level of education) had a significant effect and were
therefore left out of the models.
The scores on the dependent variables at any time
of assessment in the immediate treatment group did
not differ from those in the waiting list control group,
therefore condition as a variable was removed from
the models.
The Effect of the Course on Metacognition
The estimates of the obtained multilevel models for
metacognition and its subscales are given in Table 1.
Uncontrollability
The waiting list period did not influence the uncon-
trollability subscale significantly (t = -0.3, p [
0.25), but the course did: at post-assessment the mean
score on uncontrollability decreased significantly
(t = -4.5, p \ 0.00). These scores decreased further
at one month follow-up, and at six months follow-up. A
large effect size between the second pre-assessment of
the waiting list control group and the pre-assessment of
the immediate treatment group, and post-assessment,
was found.
Cognitive Self-consciousness
The mean score on this subscale did not decrease
significantly during the waiting period. The first
significant results were found at post-assessment
(t = -2.3, p \ 0.02). Scores increased slightly at
the 1 month follow-up, but decreased further at the
6 months follow-up assessments. The effect size of
the treatment was medium for this subscale.
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Responsibility
Scores on the responsibility subscales did not
decrease significantly until the 6 months follow-up
(t = -2.5, p \ 0.01). The effect size of the treatment
was small.
Negative Consequences
Table 1 shows that after the waiting list period, the
mean score on this scale did not change. At post-
assessment, the mean score decreased significantly
(t = -3.0, p \ 0.00). At 1 month follow-up, the sco-
res decreased further, to stabilise at 6 months follow-
up. A medium effect size of the treatment was found.
Positive Beliefs
After the waiting list period scores did not change
significantly, but they did at post-assessment (t =
-2.0, p \ 0.05). Scores decreased further at the
1 month follow-up and the 6 months follow-up. Only
a small effect size of the course was found (Table 2).
The change over time of total scale of the MCHA
is in accordance with its subscales and is therefore
not discussed in detail.
The Effect of the Course on Hypochondriacal
Complaints, Depressive Complaints and Trait
Anxiety
Hypochondriacal Complaints
During the waiting list period, no significant
decrease in scores occurred (t = 1.3, p [ 0.15). At
post-assessment, scores did decrease significantly
(t = -4.7, p \ 0.00), and scores decreased further at
1 month and 6 months follow-up. Participants in the
waiting list group did not differ from those in the
immediate treatment group with regard to their
scores on the GIAS. Being a drop out did have an
effect on the results of the GIAS (t = 2.6, p \ 0.01)
and was therefore included in the final model of this
measure.
Depressive Complaints
BDI scores remained stable during the waiting list
period (t = 0.8, p [ 0.20), but at post-assessment,
scores decreased significantly (t = -5.6, p \ 0.00).
The scores decreased further at both follow-up
assessments.
Table 2 Results for hypochondriacal complaints, depressive complaints and trait anxiety over time
Fixed effects GIAS BDI STAI
Estimate SE t Estimate SE t Estimate SE t
Intercept (mean score at t2) 96.6 4.8 13.7 1.1 52.9 1.5
Mean difference at t1 (vs. t2) 7.9 6.2 1.3 1.1 1.3 0.8 1.7 1.9 0.9
Mean difference at t3 (vs. t2) -24.0 5.1 -4.7** -5.6 1.0 -5.6** -7.5 1.6 -4.7**
Mean difference at t4 (vs. t2) -28.1 5.0 -5.6** -5.9 1.0 -5.9** -7.7 1.5 -5.1**
Mean difference at t5 (vs. t2) -36.4 5.2 -7.0** -8.1 1.1 7.4** -10.8 1.6 -6.8**
Drop out 30.7 12.0 2.6*
Between individual variance 355.5 113.4 28.0 7.9 46.6 13.9
Measurement variance 331.5 50.7 13.6 2.1 31.3 4.8
Effect size pre-post 0.9 0.9 0.8
Note. t1 = pre assessment 1 of the waiting list group; t2 = pre assessment 2 of the waiting list group + the pre assessment of the
immediate treatment group; t3 = post assessment; t4 = 1 month follow up assessment; t5 = 6 months follow up assessment.
GIAS = Groningen Illness Attitude Scale; BDI = Beck’s Depression Inventory; STAI = the trait scale of the Spielberger’s State
Trait Anxiety Inventory
* = p \ 0.01; ** = p \ 0.00
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Trait Anxiety
The STAI did not show a significant decrease after
the waiting period (t = 0.9, p [ 0.15). At post-
assessment, trait anxiety decreased significantly
(t = -4.7, p \ 0.00). The decrease continued at the
one and 6 month follow-ups.
Discussion
The present study aimed to (a) examine whether the
course ‘Coping with health anxiety’ could produce
change in metacognitive aspects, and (b), whether the
course’s earlier found beneficial effects on hypo-
chondriacal complaints, depressive symptomatology
and trait anxiety would be replicated.
Results with regard to the first question showed
that all metacognitive factors decreased during the
course and persisted during the follow-up period, and
that the course outperformed the waiting list period.
This was the first time that a change in metacognitive
aspects during a short-term, cognitive behavioral
psychoeducational course was studied.
The large decrease (with an effect size of 1.2) in
perceived uncontrollability indicates that participants
found it much less difficult to stop worrying about
illness after the course. They also changed their view
on how abnormal it is to fear illness, for example by
scoring lower on questions such as ‘I often think there
is something wrong with my way of thinking because
I find it difficult to stop thinking about illness’.
The medium-sized decrease (effect size of 0.5) in
cognitive self-consciousness indicates that people
tended to focus less on their thoughts, and felt less
need to critically examine their thoughts about illness
after the course. This effect might be due to a change
in selective attention, because participants were
taught that they focus their attention on their bodies
and illness-related cues, and how they can learn to
control and change this. Furthermore, when health
anxiety has decreased, examining thoughts about
disease is no longer required.
A medium to large change (with an effect size
equal 0.6) was found for negative consequences,
which indicates that people were no longer as worried
about the consequences of not being able to stop
thinking about illness (e.g. going crazy), or actually
contracting a serious illness by thinking about it
constantly after the course. Because the participants
were able to discuss their beliefs with other partic-
ipants, and with the course’s facilitators, they realized
that having hypochondriacal metacognitions, and
hypochondriacal cognitions, is not necessarily a sign
that they are going crazy. Furthermore, the issue of
whether it is possible to contract a serious disease just
by thinking about the disease (which is an example of
what we call ‘magical thinking’) was discussed
specifically during the course.
Small effects were found on the subscales respon-
sibility and positive beliefs (with effect sizes of 0.2
for both subscales), the first only at the 6 months
follow-up. Similar to the findings by Bouman and
Meijer (1999), who compared (a smaller number of)
hypochondriacal subjects healthy controls and psy-
chology students, the scores of our participants on
these scales were not very high. Although we did find
a significant change over time, the relationship
between responsibility and positive belief and hypo-
chondriasis is as yet unclear and should be studied
further.
Through the course and its exercises, the partic-
ipants learned how to cope actively with their health
anxiety and to gain more control over their hypo-
chondriacal complaints. Because the discussions
during the course were specifically about cognitions,
in terms of automatic thoughts and beliefs, but not
about metacognitions, the alteration of metacognitive
aspects as described above might be called implicit
instead of explicit.
Overall, the findings regarding the decrease of
metacognitive factors over time are in line with results
found in earlier, smaller, studies in which metacog-
nition changed during treatment. Wells and Sembi
(2004) found that, with a treatment focussing on
metacognition, PTSD symptoms decreased. However,
their treatment specifically targets metacognitive
factors, with an emphasis on eliciting and modifying
negative and positive beliefs about worrying, and the
development of alternative non-worry-based strate-
gies for appraising and dealing with threat.
The treatment used in the present study did not
explicitly focus on specific metacognitions partici-
pants might have. Instead, it has a format in which
hypochondriacal complaints are normalized and pre-
sented as controllable, thereby probably changing
implicit negative metacognitions about hypochondri-
acal complaints and cognitions. However, it is as yet
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unclear whether a treatment that specifically targets
hypochondriacal metacognition could be even more
beneficial. Therefore, it would be interesting to
compare a metacognitive treatment for hypochondri-
asis to the short-term psychoeducational course
‘Coping with health anxiety’.
With regard to the second research question, we
found that the course also had a beneficial effect on
hypochondriacal complaints. Furthermore, depressive
complaints and state anxiety decreased over time.
These findings were in line with earlier studies of the
‘Coping with health anxiety’ course (Bouman 2002;
Bouman and Polman 2007; Buwalda et al. 2007).
This study has several limitations. One is the
generalizability of the findings, with regard to both
the change in metacognitive aspects and hypochon-
driacal complaints. The participants of this study
were self-referred, and may differ from patients
found in general mental health care in terms of
severity of complaints and general functioning.
Another limitation is the occurrence of missing
data in this study. It is impossible to make statements
about the participants who did not return their
questionnaires. Although we found that they did not
differ from those who had returned all assessments
with regard to their pre-assessment it still should be
studied why participants decide not to return their
measurements and how they could be motivated to
return all assessments. We found that dropouts
(participants who did not complete the course) had
higher GIAS scores at the first measurement. They
did not score higher on MCHA and its subscales.
Because there were also successful completers with
high GIAS scores on their pre-assessment, we cannot
conclude that the course ‘Coping with health anxiety’
is not suitable for people with more severe hypo-
chondrial complaints. However, they may have a
lower probability to complete the course. Whether
this is due to the hypochondrial complaints or to other
related complaints is unclear as yet.
Additionally, there is is the lack of data on
comorbidity of the participants. Due to the diagnostic
instrument that was used in this study it was not
possible to determine whether participants were
eligible for concurrent diagnoses, as we only acquired
information of depressive and anxiety symptomatol-
ogy. Comorbidity information should be assessed
more thoroughly in future studies, and at post-
assessment and follow-ups it should be measured
whether participants still fulfill the diagnostic criteria
of hypochondriasis.
Unfortunately, the design of the study does not
allow a causal analysis of the data to determine
whether metacognitive aspects or hypochondrial com-
plaints were affected most by the course, and whether
hypochondrial complaints were influenced by meta-
cognition or vice versa. We can conclude however,
that the higly correlated scale scores improved simul-
taneously during the course and that this improvement
continued at least until 6 months after the course. It
seems worthwhile to study the causal mechanism of
the improvement further in a future study.
In conclusion, this study has shown that a cogni-
tive-behavioural psychoeducational group course can
produce change in both hypochondriacal metacogni-
tion and hypochondriacal complaints, and that the
decrease in several aspects of metacognition concurs
with a reduction of hypochondriacal complaints.
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